Q3 2025, Revenue declined by 7.1 % year‑on‑year (‑4.7 % ex‑FX) to €257 m, driven by a sharp drop in the Radiology Solutions division. Adjusted EBITDA fell to €5 m (2.0 % of revenue) despite cost control measures. Free cash flow turned positive at €21 m for the quarter, benefiting from working‑capital improvements and one‑off proceeds. While the Healthcare IT business saw recurring revenue growth, the analog film business continues to erode profitability and remains a drag on the group’s margin.
"This is not financial advice. All views expressed are personal interpretations of publicly available information and are not predictions or recommendations."
Disclaimer
The user RecMag has a position in ENXTBR:AGFB. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.